Targeted Cancer Therapies, From Small Molecules to Antibodies

Targeted Cancer Therapies, From Small Molecules to Antibodies
Author :
Publisher : Frontiers Media SA
Total Pages : 1123
Release :
ISBN-10 : 9782889638840
ISBN-13 : 2889638847
Rating : 4/5 (847 Downloads)

Book Synopsis Targeted Cancer Therapies, From Small Molecules to Antibodies by : Zhe-Sheng Chen

Download or read book Targeted Cancer Therapies, From Small Molecules to Antibodies written by Zhe-Sheng Chen and published by Frontiers Media SA. This book was released on 2020-07-22 with total page 1123 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Targeted Cancer Therapies, From Small Molecules to Antibodies Related Books

Targeted Cancer Therapies, From Small Molecules to Antibodies
Language: en
Pages: 1123
Authors: Zhe-Sheng Chen
Categories:
Type: BOOK - Published: 2020-07-22 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Targeted cancer therapies, from small molecules to antibodies, volume II
Language: en
Pages: 428
Authors: Zhe-Sheng Chen
Categories: Medical
Type: BOOK - Published: 2023-07-27 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Small Molecules in Oncology
Language: en
Pages: 238
Authors: Uwe M. Martens
Categories: Medical
Type: BOOK - Published: 2011-03-03 - Publisher: Springer

DOWNLOAD EBOOK

Extensive research into the molecular mechanisms of cancer disease has heralded a new age of targeted therapy. In malignant cells, key proteins that are crucial
Targeted Radionuclide Therapy
Language: en
Pages: 564
Authors: Tod W. Speer
Categories: Medical
Type: BOOK - Published: 2012-03-28 - Publisher: Lippincott Williams & Wilkins

DOWNLOAD EBOOK

Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the t
Successes and Limitations of Targeted Cancer Therapy
Language: en
Pages: 126
Authors: S. Peters
Categories: Medical
Type: BOOK - Published: 2014-02-19 - Publisher: Karger Medical and Scientific Publishers

DOWNLOAD EBOOK

The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy w